Persons living with HIV (PLWH) are living longer with antiretroviral therapy (ART). Unfortunately, older PLWH also appear to be at increased risk for HIV-associated neurocognitive disorders (HAND). In parallel, as a person ages, there is risk of developing neurodegenerative disorders of late life, including Alzheimer?s disease (AD) or its precursor, amnestic mild cognitive impairment (aMCI). A current challenge lies in disentangling HAND from the more deleterious and progressive aMCI diagnosis. Distinguishing between aMCI and HAND is critical in order to provide the most appropriate life planning, intervention and treatment options for patients and to properly identify biological mechanisms of HAND. Studies that propose to identify biological mechanisms of HAND, without careful recognition that some HAND cases may either additionally have aMCI and or may have aMCI misdiagnosed as HAND, may lead to problematical mechanistic examinations of an unclear phenotype. We believe that our proposal is particularly innovative in its approach because it first attempts to clarify the phenotype of aMCI among PLWH and then examine its neurobiologic underpinnings. Participants will include PLWH who were characterized neuropsychologically in life and also have plasma, CSF, and/or neuropathologic samples available for additional characterization. Samples and data come from the National NeuroAIDS Tissue Consortium (of which the California NeuroAIDS Tissue Network at UCSD is one of four contributing banks), the UCSD HIV Neurobehavioral Research Program (HNRP) and the UCSD Shiley-Marcos Alzheimer?s Disease Research Center (ADRC). To find aMCI among PLWH, the aims use both 1) an empirically-based neuropsychological diagnostic approach, and 2) a data-driven latent class analysis (LCA) approach, which will allow us to better identify neuropsychological and biological characteristics distinguishing HAND from aMCI. Specifically, Aim 1 will use the neuropsychological diagnostic approach to identify aMCI among PLWH and compare profiles of aMCI- and HAND-associated biological markers and neurocognitive trajectories among HIV+ and HIV- diagnostic groups.
Aim 2 will use a data-driven latent class analysis (LCA) approach to classify PLWH as aMCI, HAND or cognitively normal, and similarly compare profiles of aMCI- and HAND-associated biological markers and neurocognitive trajectories among LCA groups and HIV- diagnostic groups.
Aim 3 will compare and validate the diagnostic and LCA classification methods. The public health benefits of our project would be significant if it is able to identify PLWH who have aMCI and reliably distinguish it from HAND. This capability would: 1) allow us to apply the approach to all PLWH to aid in identification of those at increased risk for progression to AD dementia, 2) allow for appropriate treatments to be implemented, e.g., HAND-specific treatments or aMCI/AD-specific treatments, and for these to be applied as early as possible in the course of the disease, and 3) allay fears among PLWH who do not have aMCI, a significantly more debilitating disorder that confers greater risk for dementia than HAND.

Public Health Relevance

Alzheimer?s Disease (AD) and its precursor amnestic mild cognitive impairment (aMCI) are major public health problems that may go unidentified in persons living with HIV (PLWH) because they must often be detected against the backdrop of additional mild cognitive problems directly related to HIV termed HIV-associated Neurocognitive Disorders (HAND) that can sometimes include memory problems. The aim of this study is to identify unique profiles of memory and thinking skills, biomarkers in body fluids, and brain changes that can distinguish between aMCI and HAND in PLWH to allow us to know who has aMCI and may eventually develop AD, and who has HAND and may not develop AD. Being able to identify PLWH who have aMCI will allow for treatments and interventions better targeted for aMCI/AD in PLWH and help to reduce fears among PLWH who do not have aMCI, a significantly more debilitating disorder that confers greater risk for dementia than HAND.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Multi-Year Funded Research Project Grant (RF1)
Project #
1RF1AG061070-01
Application #
9646218
Study Section
Special Emphasis Panel (ZAG1)
Program Officer
Mackiewicz, Miroslaw
Project Start
2018-09-30
Project End
2023-06-30
Budget Start
2018-09-30
Budget End
2023-06-30
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Psychiatry
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093